Definition and epidemiology
An intracranial aneurysm is a localized dilation or ballooning of a weakened segment of a cerebral artery wall. The vast majority are saccular (berry) aneurysms, which form at bifurcation points where hemodynamic stress is greatest; fusiform aneurysms are less common and typically involve the vertebrobasilar system.
- Prevalence of unruptured aneurysms in the general population is approximately 2-5%, based on autopsy and imaging series.
- Most are small (under 7 mm) and never rupture.
- Annual rupture incidence (subarachnoid hemorrhage, SAH) is roughly 6-10 per 100,000 person-years in most Western populations, with higher rates reported in Japan and Finland.
- Peak age for rupture is 40-60 years.
- Women are affected more often than men, with a ratio of roughly 1.6:1, an association partly attributed to estrogen effects on vascular wall integrity.
- About 85% of aneurysms arise in the anterior circulation (anterior communicating artery, posterior communicating artery/internal carotid junction, middle cerebral artery bifurcation); the remainder arise in the posterior circulation (basilar tip, vertebral artery).
- Thunderclap headache = 'worst headache of life' is the classic presentation of ruptured aneurysm/SAH
- Non-contrast CT within 6 hours of onset is nearly 100% sensitive and sufficient to rule out SAH if normal; LP is needed when CT is done later and negative but suspicion remains
- Xanthochromia on LP is more specific than RBC count for distinguishing true SAH from traumatic tap
- Posterior communicating artery aneurysm classically causes a painful CN III palsy with pupil involvement
- Nimodipine is given to all aneurysmal SAH patients to reduce delayed cerebral ischemia, not to prevent vasospasm itself
- ADPKD is the key genetic association tested with intracranial aneurysms
- Vasospasm/delayed cerebral ischemia peaks around day 4-14 post-SAH
- Most aneurysms arise at anterior circulation bifurcations near the circle of Willis
Etiology and risk factors
Aneurysm formation reflects a combination of congenital wall weakness and acquired hemodynamic stress.
Modifiable risk factors
- Cigarette smoking (strongest modifiable risk factor, for both formation and rupture)
- Hypertension
- Heavy alcohol use
- Sympathomimetic drug use (cocaine, amphetamines)
Non-modifiable / genetic associations
- Autosomal dominant polycystic kidney disease (ADPKD)
- Family history of intracranial aneurysm or SAH (first-degree relative doubles risk)
- Connective tissue disorders: Ehlers-Danlos syndrome type IV, Marfan syndrome, neurofibromatosis type 1
- Fibromuscular dysplasia
- Coarctation of the aorta
- Female sex, older age
Risk factors for rupture (vs. simple presence)
- Aneurysm size greater than 7 mm (risk increases progressively with size)
- Posterior circulation or posterior communicating artery location
- Irregular shape, daughter sac/bleb formation
- Growth on serial imaging
- Smoking and uncontrolled hypertension
Pathophysiology
Chronic hemodynamic stress at arterial bifurcations causes degeneration of the internal elastic lamina and thinning of the medial smooth muscle layer, producing a saccular outpouching lined only by intima and adventitia. This structurally weak wall is prone to progressive stretching and eventual rupture, particularly when superimposed on hypertension or sudden Valsalva-type pressure spikes.
Rupture releases arterial blood directly into the subarachnoid space, causing an abrupt rise in intracranial pressure. This produces the hallmark thunderclap headache and can trigger a transient fall in cerebral perfusion, loss of consciousness, and brainstem-mediated reflexes (e.g., sudden cardiac arrhythmia). Blood breakdown products in the CSF cause chemical meningeal irritation (meningismus), and clot or vasospasm in surrounding vessels can later cause delayed cerebral ischemia.
Clinical features
Unruptured aneurysm
- Usually asymptomatic, found incidentally on imaging
- Larger aneurysms may cause mass effect: cranial nerve III palsy with a dilated, non-reactive pupil (classic for posterior communicating artery aneurysm), visual field defects (ophthalmic artery aneurysm), or facial pain
Ruptured aneurysm (subarachnoid hemorrhage)
- Sudden, severe 'thunderclap' headache, often described as the worst headache of the patient's life, reaching peak intensity within seconds to minutes
- Nausea and vomiting
- Transient or persistent loss of consciousness
- Meningismus: neck stiffness, photophobia (may take hours to develop)
- Focal neurologic deficits depending on location
- Seizures in a minority of patients
- Sentinel headache: a milder warning headache in the days to weeks preceding major rupture, caused by a small leak, present in up to a third of patients and often misdiagnosed
Diagnosis
Suspected rupture (acute SAH workup)
- Non-contrast CT head - first-line; when performed within 6 hours of symptom onset, sensitivity approaches 100% and a normal scan effectively rules out SAH. Sensitivity declines with later imaging.
- Lumbar puncture - indicated if CT is performed beyond the 6-hour window and is negative, or if clinical suspicion remains high despite an early negative CT; look for xanthochromia (more specific than red cell count, which can reflect a traumatic tap) and elevated opening pressure
- CT angiography (CTA) - localizes the aneurysm and guides treatment planning once SAH is confirmed
- Digital subtraction angiography (DSA) - remains the gold standard for aneurysm detection and characterization, especially when CTA is equivocal
Screening for unruptured aneurysm
- MR angiography (MRA) or CTA is used for screening in high-risk groups: ADPKD, strong family history (two or more affected first-degree relatives), or connective tissue disease
- Routine population screening is not recommended
Grading scales (prognostic, used clinically)
- Hunt and Hess scale - clinical severity grading based on neurologic exam
- World Federation of Neurosurgical Societies (WFNS) scale - based on Glasgow Coma Scale and focal deficit
- Fisher scale (and modified Fisher) - CT-based, predicts risk of vasospasm from clot burden and distribution
Differential diagnosis
- Migraine with aura - gradual onset over minutes to hours, prior similar episodes, lacks meningismus
- Tension-type headache - bilateral, non-pulsatile, gradual onset
- Reversible cerebral vasoconstriction syndrome (RCVS) - recurrent thunderclap headaches, often triggered by Valsalva or vasoactive drugs, normal or near-normal initial CT
- Cervical artery dissection - neck pain, Horner syndrome, younger patients, trauma history
- Cerebral venous sinus thrombosis - subacute headache, papilledema, seizures
- Meningitis/encephalitis - fever, more gradual onset, CSF pleocytosis
- Pituitary apoplexy - headache with visual field defect and acute hypopituitarism
- Primary (benign) thunderclap headache - diagnosis of exclusion after negative imaging and LP
Management
Unruptured aneurysm
Management balances rupture risk against treatment risk and depends on size, location, morphology, patient age, and comorbidities. Guideline consensus (AHA/ASA, major neurosurgical societies):
- Small aneurysms (under 7 mm), especially in the anterior circulation and in older patients, are often managed with serial imaging surveillance (MRA/CTA at intervals)
- Larger, growing, irregular, symptomatic, or posterior circulation aneurysms generally warrant preventive treatment
- Smoking cessation and blood pressure control are advised in all patients with unruptured aneurysms
- Treatment options: endovascular coiling (with or without stent/flow-diverter assistance) or surgical clipping; choice depends on aneurysm anatomy, patient factors, and center expertise
Ruptured aneurysm (acute SAH) - emergency management
- Stabilize airway, breathing, circulation; manage in a neurocritical care or ICU setting
- Strict blood pressure control to prevent rebleeding before definitive treatment, balanced against maintaining cerebral perfusion
- Early aneurysm securing (within 24-72 hours) by endovascular coiling or surgical clipping to prevent rebleeding; international registry data generally favor coiling when anatomically feasible (ISAT trial), though clipping remains preferred for certain anatomy (e.g., wide-necked MCA aneurysms, associated hematoma needing evacuation)
- Nimodipine (oral calcium channel blocker) is given to all patients with aneurysmal SAH to reduce delayed cerebral ischemia and improve neurologic outcome, though it does not clearly prevent angiographic vasospasm
- Monitoring for and treatment of vasospasm/delayed cerebral ischemia: transcranial Doppler and/or CTA/DSA surveillance; management includes maintaining euvolemia and induced hypertension, with endovascular intra-arterial vasodilators or balloon angioplasty for refractory cases
- Management of hydrocephalus: external ventricular drain for acute obstructive hydrocephalus; ventriculoperitoneal shunt if chronic hydrocephalus persists
- Seizure prophylaxis is considered selectively, not routinely in all patients, per most current guidelines
- Supportive care: analgesia, antiemetics, DVT prophylaxis, electrolyte monitoring (hyponatremia from cerebral salt wasting or SIADH is common)
Complications and prognosis
- Rebleeding - highest risk in the first 24 hours after initial rupture if untreated; carries high mortality
- Delayed cerebral ischemia / vasospasm - typically occurs days 4-14 post-SAH, a major cause of morbidity
- Hydrocephalus - acute (obstructive, from clot) or chronic (communicating, from impaired CSF resorption)
- Hyponatremia - from cerebral salt wasting syndrome or SIADH
- Seizures
- Cardiac complications - neurogenic stunned myocardium, arrhythmias, from catecholamine surge
Overall mortality from aneurysmal SAH is high: roughly a third of patients die before reaching the hospital or shortly after, and overall case fatality is approximately 25-50% depending on the series. Among survivors, a substantial proportion have long-term cognitive or functional deficits. Outcome correlates strongly with initial clinical grade (Hunt and Hess/WFNS) and amount of blood on CT (Fisher grade). Unruptured, untreated small aneurysms carry a low annual rupture risk, but risk accumulates over a lifetime, which underlies the rationale for treating larger or higher-risk lesions.
PICNIC for aneurysm risk factors: Polycystic kidney disease, Infection (mycotic), Connective tissue disease (Ehlers-Danlos, Marfan), Nicotine (smoking), Increased blood pressure (hypertension), Coarctation of the aorta/Cocaine use.
Practice questions
1. A 52-year-old woman presents to the emergency department with a sudden, severe headache that began abruptly while she was lifting weights, described as the worst she has ever had. She has associated nausea and photophobia but no focal weakness. Non-contrast CT of the head performed 12 hours after symptom onset is normal. What is the most appropriate next step?
2. A 45-year-old man with a known 4 mm unruptured anterior communicating artery aneurysm, discovered incidentally, is a current smoker with well-controlled blood pressure. He is asymptomatic. Which of the following is the most appropriate management approach based on current guideline consensus?
3. A 60-year-old woman is admitted with confirmed aneurysmal subarachnoid hemorrhage, Hunt and Hess grade II, and undergoes successful endovascular coiling on hospital day 1. On hospital day 7, she develops new confusion and worsening left-sided weakness. Which complication is most likely responsible for this new deficit?
Frequently asked questions
What causes an intracranial aneurysm?
Intracranial aneurysms form from chronic weakening of the arterial wall at branch points, usually near the circle of Willis, caused by hemodynamic stress combined with risk factors such as smoking, hypertension, and genetic predisposition. Conditions like autosomal dominant polycystic kidney disease, Ehlers-Danlos syndrome, and a family history of aneurysm or subarachnoid hemorrhage increase risk. Most aneurysms develop over years and many never rupture.
What are the first symptoms of a ruptured intracranial aneurysm?
The first symptom is typically a sudden, severe thunderclap headache that reaches maximum intensity within seconds to minutes, often called the worst headache of the patient's life. This is frequently accompanied by nausea, vomiting, neck stiffness, photophobia, and sometimes brief loss of consciousness or seizure. Some patients report a milder sentinel headache days to weeks earlier from a small warning leak.
How is an intracranial aneurysm diagnosed?
Diagnosis of rupture starts with a non-contrast CT scan, which is nearly 100% sensitive when performed within the first 6 hours of symptom onset. If CT is done later and is negative but suspicion remains, a lumbar puncture checks for xanthochromia and elevated red cells. CT angiography or catheter-based digital subtraction angiography is then used to locate and characterize the aneurysm for treatment planning; unruptured aneurysms are usually found incidentally or detected by MRA/CTA screening in high-risk patients.
Is an intracranial aneurysm curable?
An intracranial aneurysm can be effectively treated and the rupture risk eliminated, but it is not 'cured' in the sense of reversing the underlying vessel wall weakness. Endovascular coiling or surgical clipping secures the aneurysm and prevents future bleeding from that specific lesion. However, patients with one aneurysm have an increased lifetime risk of forming additional aneurysms, so ongoing risk factor control and sometimes periodic imaging are advised.
Aneurysmal subarachnoid hemorrhage vs. traumatic subarachnoid hemorrhage — what is the difference?
Aneurysmal SAH results from spontaneous rupture of a weakened arterial wall, presents with sudden thunderclap headache without preceding trauma, and shows blood concentrated around the basal cisterns and circle of Willis on CT. Traumatic SAH follows head injury, shows blood distributed over the brain convexities near the site of impact, and is often accompanied by other injury findings like skull fracture or contusion. Distinguishing the two is important because aneurysmal SAH requires urgent vascular imaging and aneurysm treatment, while traumatic SAH management focuses on the broader traumatic brain injury.
Key drugs
Related conditions and differentials
Sources and further reading
StatPearls (NCBI Bookshelf)MedlinePlusWHO ICD-10: I67.1
Educational content for medical students, prepared by the WhiteCoat Pro editorial team with AI assistance; every page is reviewed by a second AI model for factual errors. It is not medical advice and does not replace the product label, local guidelines or a clinician.